Neuralink, Elon Musk’s neurotechnology company, successfully performed two brain-computer interface (BCI) implants within 24 hours, marking a significant operational milestone. With nine human participants now implanted, Neuralink aims to reach 20 implants by year-end. The technology targets neurological disorders such as spinal cord injury and ALS, with current users extensively engaging with the devices. Plans involve expanding electrode counts for deeper brain access and integration with artificial intelligence by 2028. Google DeepMind’s CEO praised the innovation, highlighting growing interest in BCI technologies.